[VRDN] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
11-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -4.76%
YoY- -191.66%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 4,784 1,192 1,631 718 462 756 889 207.40%
PBT -4,661 -6,386 -5,834 -7,312 -6,980 -5,570 -1,839 85.99%
Tax 167 77 113 102 30 -71 0 -
NP -4,661 -6,386 -5,834 -7,312 -6,980 -5,570 -1,839 85.99%
Tax Rate - - - - - - - -
Total Cost 9,445 7,578 7,465 8,030 7,442 6,326 2,728 129.03%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin -97.43 -535.74 -357.69 -1,018.38 -1,510.82 -736.77 -206.86 -39.49%
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -2.64 -4.30 -4.06 -5.12 -9.06 -7.23 -2.56 2.07%
EPS Diluted -2.64 -4.30 -4.06 -5.12 -9.06 -7.23 -2.56 2.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.